Roche Pharma has introduced Tecentriq, India's first under-the-skin immunotherapy for lung cancer. This new injection takes about seven min...

F. Hoffmann-La Roche AG has approached the Supreme Court. This follows a Delhi High Court decision permitting Natco Pharma to introduce a g...

The Delhi High Court has permitted Natco Pharma to launch its affordable generic version of risdiplam, a crucial drug for spinal muscular a...

The Delhi High Court has ordered Natco Pharma to maintain status quo on the launch of Risdiplam until April 2. Roche, which holds the paten...

Roche Pharma India has announced that Rajwinder Mehdwan will take over as the country general manager from April 1, 2025, replacing V Simps...

Roche Pharma India launches Vabysmo, a medication for neovascular age-related macular degeneration and diabetic macular edema in India. The...

The company has introduced Ocrevus (Ocrelizumab) which is the first and only approved disease modifying therapy for both Relapsing Remittin...

PHESGO was first approved by the US FDA in June 2020 during the peak of the Covid pandemic, by the European Medicines Agency (EMA) in Decem...

Since its launch, over 4,000 SMA patients across over 50 countries have benefitted from the drug, Roche said in a statement.

Roche said that the production process for this drug is “very complex” and the company will do everything to ensure an equitable distributi...

Roche Pharma India has signed a "distribution agreement with Cipla to expand the scope of the partnership to include, marketing and distrib...

A Roche India spokesperson confirmed the development and said an announcement for a new India head will be made soon. “Dec. 1 will be the d...

Roche said this partnership will also enable it to focus on bringing new, transformative medicines to patients in India.

The pharma major will distribute Tocilizumab and Syndyma -- the second brand of Roche's cancer therapy bevacizumab -- in India.

Roche Products (India) Private Ltd is a wholly owned subsidiary of the Switzerland based Roche Group and has products in therapeutic areas .

The Delhi HC ruling favouring India’s second largest drugmaker Cipla has come as a shot in the arm for other generic makers who are fightin...

Roche announced on Thursday that it had signed a marketing agreement with domestic company Elder Pharma for its osteoporosis drug, Bonviva.